RxDoctor Payments Data

David Betten, MD

Emergency Medicine · Lansing, MINPI 1649379736

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Johnson & Johnson at 44.4% of the total. Reporting peaked in 2019 at $287 and has fallen 94.9% since, to $15 in 2025. Among emergency medicine clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$402in general payments, 2019–2025

Across 36 payments — averaging $11.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$179
  • E.r. Squibb & Sons, L.L.C.$81
  • Mallinckrodt Enterprises LLC$42
  • Mallinckrodt Hospital Products Inc.$41
  • Getinge USA Sales, LLC$25
  • CSL Behring$20
  • plus $15 from 1 others

What the payments were for

  • Food & beverage$38295%
  • Education$205%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$402 in reported general payments places this provider in the 90th percentile of 2,532 emergency medicine providers in Michigan.

See all emergency medicine providers in Michigan →

Medicare billing

Part B allowed, 2024
$46,057
Medicare patients
252
Services billed
310

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl74$13,010
Ondansetron OdtOndansetron19$169
Amlodipine Besylate12$61

Paid to pharmacies, not to this prescriber.

Other emergency medicine in Lansing

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →